Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013;25(2):181-5.
doi: 10.1080/09540121.2012.687821. Epub 2012 May 29.

Prospective prediction of viral suppression and immune response nine months after ART initiation in Seattle, WA

Jane M Simoni  1 , Samantha S Yard, David Huh
Affiliations

Prospective prediction of viral suppression and immune response nine months after ART initiation in Seattle, WA

Jane M Simoni et al. AIDS Care. 2013.

Abstract

Knowing at antiretroviral therapy (ART) initiation which patients might be at greatest risk for failure to achieve viral suppression would enable providers to target patients most in need and tailor their care appropriately. This study involved multilevel modeling of data from a randomized controlled trial among outpatients in Seattle, WA, USA. The 224 participants initiating or switching ART at baseline were 24% female, 34% heterosexual, and 47% Caucasian. Of 24 baseline demographic and psychosocial patient-level variables modeled in separate generalized estimating equations, only employment predicted changes in HIV-1 RNA viral load or CD4 lymphocyte count over the course of the 9-month trial. Although the findings require replication, they suggest adherence support strategies should emphasize close monitoring and support for all patients initiating ART.

PubMed Disclaimer

References

    1. Amico KR, Konkle-Parker DJ, Cornman DH, Barta WD, Ferrer R, Norton WE, Fisher WA. Reasons for ARTnon-adherence in the deep south: Adherence needs of a sample of HIV-positive patients in Mississippi. AIDS Care. 2007;19:1210–1218. doi: 10.1080/09540120701426516. - DOI - PMC - PubMed
    1. Ammassari A, Trotta MP, Murri R, Castelli F, Narciso P, Noto P, Antinori A. Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. Journal of Acquired Immune Deficiency Syndromes (1999) 2002;31(Suppl 3):S123–S127. - PubMed
    1. Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, Moss A. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS (London England) 2000;14:357–366. - PubMed
    1. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Methodological. 1995;57:289–300.
    1. Carballo E, Cadarso-Suárez C, Carrera I, Fraga J, de la Fuente J, Ocampo A, Prieto A. Assessing relationships between health-related quality of life and adherence to antiretroviral therapy. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment Care and Rehabilitation. 2004;13:587–599. - PubMed

Publication types

MeSH terms